![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, October 31, 2018 12:56:26 PM
Reservatrol Study results at 1 year:
"Preliminary results provided from an interim evaluation after 12 months (halfway) in the trial revealed significant benefits of RES vs placebo. Headline results included that RES reduced the loss of bone mineral density in the neck of the femur resulting in a 12% improvement in the FRAX t-score, a 36% reduction in hip fracture risk and a 9% reduction in the 10 year risk of a major osteoporotic fracture."
The core tech of this company is to synthesize natural compounds in yeast, but on an industrial scale, producing exact replicas of the natural compounds but with lower cost and higher purity. From what I can tell, their yeast-based process is one of the most advanced in the world, and has some decent IP to protect it.
Applications today cover reservatrol, nootkatone, stevia extracts, vanillin, and valencene, but the approach would seem to be applicable to many many other natural compounds (I'm thinking canabinoids).
I am taking a long position in Evola this week.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM